Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y H Shih

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|July 1, 1991
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationshipsI Sircar, E K Gregor, K R Anderson, et al.
Neuroscience|February 28, 2016
Hypertension impairs hippocampus-related adult neurogenesis, CA1 neuron dendritic arborization and long-term memoryY-H Shih, S-F Tsai, S-H Huang, et al.
Neuroimage|December 20, 2003
MEG localization of rolandic spikes with respect to SI and SII cortices in benign rolandic epilepsyY Y Lin, Y H Shih, K P Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907T A Pugsley, M D Davis, H C Akunne, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonistT A Pugsley, C L Christofferson, A Corbin, et al.
Physical Chemistry Chemical Physics : PCCP|April 8, 2010
A chemical dynamics, kinetics, and theoretical study on the reaction of the cyano radical (CN; X(2)Sigma+) with phenylacetylene (C6H5CCH; X(1)A1)Chris J Bennett, Sébastien B Morales, Sébastien D Le Picard, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomersL T Meltzer, B W Caprathe, C L Christoffersen, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|September 1, 1992
[Epidemiologic study of head injuries in Taipei City, Taiwan]L S Lee, Y H Shih, W T Chiu, et al.
Neurological Research|January 15, 1998
A nationwide epidemiological study of spinal cord injuries in Taiwan from July 1992 to June 1996H Y Chen, W T Chiu, S S Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effectsT A Rugsley, M D Davis, H C Akunne, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|July 1, 1991
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationshipsI Sircar, E K Gregor, K R Anderson, et al.
Neuroscience|February 28, 2016
Hypertension impairs hippocampus-related adult neurogenesis, CA1 neuron dendritic arborization and long-term memoryY-H Shih, S-F Tsai, S-H Huang, et al.
Neuroimage|December 20, 2003
MEG localization of rolandic spikes with respect to SI and SII cortices in benign rolandic epilepsyY Y Lin, Y H Shih, K P Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907T A Pugsley, M D Davis, H C Akunne, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonistT A Pugsley, C L Christofferson, A Corbin, et al.
Physical Chemistry Chemical Physics : PCCP|April 8, 2010
A chemical dynamics, kinetics, and theoretical study on the reaction of the cyano radical (CN; X(2)Sigma+) with phenylacetylene (C6H5CCH; X(1)A1)Chris J Bennett, Sébastien B Morales, Sébastien D Le Picard, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomersL T Meltzer, B W Caprathe, C L Christoffersen, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|September 1, 1992
[Epidemiologic study of head injuries in Taipei City, Taiwan]L S Lee, Y H Shih, W T Chiu, et al.
Neurological Research|January 15, 1998
A nationwide epidemiological study of spinal cord injuries in Taiwan from July 1992 to June 1996H Y Chen, W T Chiu, S S Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effectsT A Rugsley, M D Davis, H C Akunne, et al.
Pageof 7